Feb 20, 2018 Feb 20, 2018 ENTYVIO® (vedolizumab) Shows Higher Rates of Mucosal Healing Versus TNFα-Antagonist Therapy in Ulcerative Colitis and Crohn’s Disease Patients Feb 01, 2018 Feb 01, 2018 Takeda Canada Inc. certified by Top Employers Institute for its exceptional employee offerings